PrihodkiDobičekKGVVečkratnik prihodkov (KUV)EBITDividendaDelniceTržna kapitalizacijaDolžniško financiranjeObveznostiLastniški kapitalAAQSzaposleniROEROAROCE
Crinetics Pharmaceuticals Delnica

Crinetics Pharmaceuticals Dividenda 2024

Crinetics Pharmaceuticals Dividenda

0 USD

Crinetics Pharmaceuticals Donosnost dividend

Simbol

CRNX

ISIN

US22663K1079

WKN

A2JQTJ

Koliko dividende izplača Crinetics Pharmaceuticals 2024?

Po trenutnih podatkih z dne september 2024 je Crinetics Pharmaceuticals v zadnjih 12 mesecih izplačal skupno dividendo v višini 0 USD na delnico. Pri trenutnem Crinetics Pharmaceuticals tečaju 50,39 USD to ustreza donosnosti dividende 0 %. Dividenda se izplača krat na leto.

=

Zgodovinske Crinetics Pharmaceuticals dividende

Vsako leto se dividend izplača krat. Zadnje leto so bili meseci izplačil in .

Dan izplačilaDividenda

Je Crinetics Pharmaceuticals dividenda varna?

Crinetics Pharmaceuticals povečuje dividendo že 0 let.

V zadnjih 8 letih je Crinetics Pharmaceuticals to vrednost povečal za 0 % letno.

V petletnem obdobju se je izplačilo povečalo za 0 %.

Analitiki za tekoče poslovno leto pričakujejo rast Znižanje dividend za −100,000%.

Podrobnosti o dividendah

Razumevanje dividendnih izplačil od Crinetics Pharmaceuticals

Dividende od Crinetics Pharmaceuticals so del dobička podjetja, ki se izplača delničarjem. So ključen kazalec finančnega zdravja podjetja in privlačnosti za vlagatelje. Dividende vlagateljem nudijo stalni vir dohodka, poleg dobičkov, ki se lahko pridobijo s prodajo delnice po višji ceni od nakupne.

Primerjava iz leta v leto

Proučevanje dividendnih izplačil od Crinetics Pharmaceuticals čez leta lahko izpostavi donosnost in stabilnost podjetja. Konstantna ali naraščajoča dividendna izplačila lahko kažejo na finančno zdravo podjetje s predvidljivimi dobički, medtem ko lahko nihanje ali znižanja dividend nakazujejo na obstoječe finančne ali operativne izzive.

Vplivi na investicije

Izplačila dividend od Crinetics Pharmaceuticals so ključni dejavnik za vlagatelje, ki so usmerjeni na dohodek. Močno izplačilo dividend lahko poveča privlačnost delnice in zagotovi redni dohodek poleg morebitnih kapitalskih dobičkov. Lahko tudi pokaže zaupanje podjetja v svoje prihodnje dobičke in je tako pomemben dejavnik pri odločitvah o naložbah.

Interpretacija nihanj dividend

Spremembe v dividendah od Crinetics Pharmaceuticals lahko nastopijo zaradi sprememb v dobičkih podjetja, finančni politiki ali strategijah reinvestiranja. Povečanje dividend pogosto signalizira finančno stabilnost, medtem ko znižanje lahko nakazuje na potrebo po ohranjanju denarnih sredstev ali reinvestiranju dobičkov za spodbujanje rasti, pri čemer ima vsak scenarij različne posledice za vlagatelje.

Crinetics Pharmaceuticals Aktienanalyse

Kaj počne Crinetics Pharmaceuticals?

Crinetics Pharmaceuticals Inc. is a leading biopharmaceutical company specializing in the development and commercialization of innovative therapies for rare endocrine diseases and hormone-dependent tumors. The company was founded in 2008 by a team of experienced pharmacy professionals and is headquartered in San Diego, California. History Crinetics Pharmaceuticals was founded based on groundbreaking research in the field of endocrine diseases. The company aims to develop innovative therapies for rare endocrine diseases and hormone-dependent tumors that have been inadequately treated thus far. Crinetics draws on decades of experience and in-depth knowledge in the fields of endocrinology, neuroscience, and cancer research. Business model Crinetics is a research and development company specializing in the discovery, development, and commercialization of drugs for rare endocrine diseases. The company has an extensive portfolio of proprietary compounds based on novel mechanisms of action that are in various stages of development. Crinetics works closely with leading experts in the field of endocrinology and oncology to develop and commercialize groundbreaking new therapies. Different divisions Crinetics specializes in the research, development, and commercialization of products that can be used in rare endocrine diseases and hormone-dependent tumors. The company operates in various areas, including: - Acromegaly: Crinetics is developing a medication for the treatment of acromegaly, a rare disease caused by overproduction of growth hormone. - Cushing's syndrome: Crinetics is developing a medication for the treatment of Cushing's syndrome, a rare disease caused by overproduction of cortisol. - Hypoparathyroidism: Crinetics is developing a medication for the treatment of hypoparathyroidism, a rare disease characterized by insufficient production of parathyroid hormone. - Neuroendocrine tumors: Crinetics is developing a medication for the treatment of neuroendocrine tumors, a rare group of tumors that arise from neuroendocrine cells. Products Crinetics has an extensive portfolio of innovative products based on novel mechanisms of action that are in various stages of development. The company focuses on developing drugs that can be used in rare endocrine diseases and hormone-dependent tumors. Some of the notable products are: - CRN00808: CRN00808 is a medication that can help improve the body's monitoring system that regulates the release of growth hormones. It is currently in phase 2 clinical trials. - CRN01941: CRN01941 is a medication for the treatment of Cushing's syndrome. It has been developed to inhibit excessive production of cortisol and is currently in phase 2 clinical trials. - CRN04777: CRN04777 is a medication for the treatment of acromegaly. It has been developed to inhibit overproduction of growth hormone and is currently in phase 1 clinical trials. - CRN04894: CRN04894 is a medication for the treatment of hypoparathyroidism. It has been developed to stimulate parathyroid hormone production and is currently in phase 1 clinical trials. Conclusion Crinetics Pharmaceuticals is a leading biopharmaceutical company specializing in the development of innovative therapies for rare endocrine diseases and hormone-dependent tumors. The company has an extensive portfolio of proprietary compounds based on novel mechanisms of action that are in various stages of development. Crinetics works closely with leading experts in the field of endocrinology and oncology to develop and commercialize groundbreaking new therapies. Crinetics Pharmaceuticals je eno izmed najbolj priljubljenih podjetij na Eulerpool.com.
Delniški varčevalni načrti ponujajo privlačno možnost za vlagatelje, da dolgoročno zgradijo premoženje. Eden glavnih prednosti je tako imenovani učinek povprečenja stroškov: Z rednim vlaganjem fiksnega zneska v delnice ali delniške sklade se avtomatsko kupi več enot, ko so cene nizke, in manj, ko so visoke. To lahko vodi do ugodnejše povprečne cene na enoto s časom. Poleg tega delniški varčevalni načrti omogočajo tudi malim vlagateljem dostop do dragih delnic, saj se lahko pridružijo že z majhnimi zneski. Redna investicija tudi spodbuja disciplinirano investicijsko strategijo in pomaga izogibati se čustvenim odločitvam, kot so impulzivno kupovanje ali prodaja. Poleg tega vlagatelji profitirajo od potencialne rasti vrednosti delnic kot tudi od izplačil dividend, ki se lahko reinvestirajo, kar povečuje učinek obrestnega obrestovanja in s tem rast investiranega kapitala.

Pogosta vprašanja o delnici Crinetics Pharmaceuticals

Koliko dividende izplača Crinetics Pharmaceuticals?

V zadnjih 12 mesecih je Crinetics Pharmaceuticals izplačal dividendo v višini . To ustreza približni donosnosti dividend . V prihajajočih 12 mesecih bo Crinetics Pharmaceuticals predvidoma izplačal dividendo v višini 0 USD.

Kakšen je donos dividend od Crinetics Pharmaceuticals?

Trenutni donos od dividend za Crinetics Pharmaceuticals znaša .

Kdaj Crinetics Pharmaceuticals izplača dividend?

Crinetics Pharmaceuticals izplačuje četrtletno dividendo. Ta se izplačuje v mesecih .

Kako varna je dividenda od Crinetics Pharmaceuticals?

Crinetics Pharmaceuticals je v zadnjih 0 letih vsako leto izplačeval dividend.

Kakšna je dividenda od Crinetics Pharmaceuticals?

V naslednjih 12 mesecih se pričakuje dividende v višini 0 USD. To ustreza dividendnemu donosu 0 %.

V katerem sektorju se nahaja Crinetics Pharmaceuticals?

Crinetics Pharmaceuticals je razvrščen v sektor 'Zdravje'.

Wann musste ich die Aktien von Crinetics Pharmaceuticals kaufen, um die vorherige Dividende zu erhalten?

Da si prejel zadnjo dividendo Crinetics Pharmaceuticals z dne 9. 9. 2024 v višini 0 USD, si moral imeti delnico v depoju pred dnevom brez pravice do dividende (Ex-Tag) 9. 9. 2024.

Kdaj je Crinetics Pharmaceuticals izplačal zadnjo dividendo?

Zadnje izplačilo dividende je bilo 9. 9. 2024.

Kakšna je bila dividenda od Crinetics Pharmaceuticals v letu 2023?

V letu 2023 je Crinetics Pharmaceuticals 0 USD izplačal kot dividende.

V kateri valuti Crinetics Pharmaceuticals izplača dividendo?

Dividende od Crinetics Pharmaceuticals se izplačujejo v USD.

Andere Kennzahlen von Crinetics Pharmaceuticals

Naša analiza delnic Crinetics Pharmaceuticals Prihodki vključuje pomembne finančne kazalnike, kot so prihodki, dobiček, razmerje cena/dobiček (KGV), razmerje cena/prihodki (KUV), EBIT ter informacije o dividendah. Prav tako preučujemo aspekte, kot so delnice, tržna kapitalizacija, dolgovi, lastniški kapital in obveznosti Crinetics Pharmaceuticals Prihodki. Če iščete podrobnejše informacije o teh temah, na naših podstraneh nudimo obsežne analize: